Cell Signaling Technology

Neurofilament-L (C28E10) Horse Chimeric Monoclonal Antibody

#31220 · $152

17
Citing papers
704
Combined citations
Supplier page Find this product

Research areas

RNA modifications and cancer4Cancer-related gene regulation3Cancer-related Molecular Pathways3Glycosylation and Glycoproteins Research3Cancer-related molecular mechanisms research2Chronic Lymphocytic Leukemia Research2Advanced Breast Cancer Therapies2Galectins and Cancer Biology2

Papers citing this product

1
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
British Journal of Cancer·2006·257 cit.·DOI
2
The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1
Journal of Biological Chemistry·2014·116 cit.·DOI
3
Intermittent Fasting Improves High-Fat Diet-Induced Obesity Cardiomyopathy via Alleviating Lipid Deposition and Apoptosis and Decreasing m6A Methylation in the Heart
Nutrients·2022·65 cit.·DOI
4
ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins
Journal of Pharmacology and Experimental Therapeutics·2020·54 cit.·DOI
5
CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway
Cancers·2021·35 cit.·DOI
6
Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3β
Canadian Journal of Anesthesia/Journal canadien d anesthésie·2008·35 cit.·DOI
7
Ecrg4 peptide is the ligand of multiple scavenger receptors
Scientific Reports·2018·34 cit.·DOI
8
Inhibition of NF-κB–Mediated Signaling by the Cyclin-Dependent Kinase Inhibitor CR8 Overcomes Prosurvival Stimuli to Induce Apoptosis in Chronic Lymphocytic Leukemia Cells
Clinical Cancer Research·2013·32 cit.·DOI
9
O-GlcNAc stabilizes SMAD4 by inhibiting GSK-3β-mediated proteasomal degradation
Scientific Reports·2020·30 cit.·DOI
10
Recent advances in targeting protein kinases and pseudokinases in cancer biology
Frontiers in Cell and Developmental Biology·2022·23 cit.·DOI

Similar products

ProductVendorPricePapers
Neurofilament-L (C28E10) Feline Chimeric Monoclonal AntibodyFeline chimericCell Signaling Technology$152200
Neurofilament-L (C28E10) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$152100
Neurofilament-L (C28E10) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$865100
Neurofilament-L (DA2) Mouse Monoclonal AntibodyMouseCell Signaling Technology$147100
Neurofilament-L (C28E10) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)RabbitCell Signaling Technology$465100
Neurofilament-L (C28E10) Rabbit Monoclonal Antibody (Alexa Fluor® 594 Conjugate)RabbitCell Signaling Technology$46593
Neurofilament-L (E4Z2P) Mouse Monoclonal AntibodyMouseCell Signaling Technology$1588
Neurofilament-L (E3V7Y) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$8653
Neurofilament-L (DA2) Mouse Monoclonal Antibody (BSA and Azide Free)MouseCell Signaling Technology$8652
Neurofilament-L (C28E10) Mouse Chimeric Monoclonal AntibodyMouse chimericCell Signaling Technology$152—